Have you been diagnosed with multiple myeloma that has not responded to treatment or has come back after treatment? If so, you may be able to take part in a research study looking at the safety and efficacy of giving a new drug called ABBV-383 to patients with relapsed/refractory multiple myeloma.

Do you have a history of ACL reconstruction? You may be eligible to participate in a study using virtual reality and mindfulness meditation! We aim to explore psychological factors that may impact return to play outcomes after ACL reconstruction.

This is a Phase Ib/II, open-label, multicenter, randomized, umbrella study in patients with locally advanced SCCHN. The study will enroll treatment-naive patients with resectable Stage III-IVA HPV-negative, PD-L1 positive SCCHN with measurable disease.

Do you have endometrial cancer? if so, you may be able to participate in an observational study that follows patients from diagnosis of endometrial cancer through one year post-treatment to learn more about how cancer treatment affects individual patients.

Do you have ovarian or peritoneal cancer? if so, you may be able to participate in a research study comparing the treatment of carboplatin/paclitaxel and letrozole hormonal therapy to letrozole alone to see if the treatment can shrink or stabilize your cancer.

Este estudio analizará el efecto que tiene la ideología de género y la ideología lingüística en algunas formas novedosas del español. In this study, we want to learn how gender and beliefs and attitudes about language affect how people feel about aspects of the Spanish language.

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer. If so, you may be able to take part in a research study looking at the safety of giving Docetaxel vs Docetaxel and Radium-223 to patients.

Have you been diagnosed with uterine cancer called endometrial serous carcinoma or carcinosarcoma? If so, you may be able to take part in a research study to test if adding a drug or drugs that target HER2 proteins in addition to the usual combination of chemotherapy drugs could prevent your cancer from returning or shrink your cancer.

We're all different. But when we visit the doctor, our treatments are often the same. We think one day health care should be tailored for you. This is called precision medicine. And research can help us get there. Taking part in the All of Us Research Program involves sharing information about your health, habits, and what it's like where you live. If you are 18 or older and live in the United States, you may be able to take part!

The goal of the study is to understand why teams perform better than individuals. In the study, participants will work in small groups of 2-4 members to solve a simple logic puzzle. It is a fun and engaging study to explore why teams perform better than individuals. If you are a student at UNC and 18 years or older, you may be able to take part.